TOVX (TOVX) Stock Price & Analysis
TOVX (TOVX) rose 0.00% to USD 0.25 as of September 8, 2026 at 12:50 UTC, according to Nexqual real-time market data.
TOVX last closed at USD 0.25; the session ranged USD 0.25–0.26 on volume of 425,243 shares. Market capitalization is —, with a 52-week range of USD 0.16–0.86 (ASE). Source: Nexqual, September 8, 2026 at 12:50 UTC.
Key Statistics (as of September 8, 2026 at 12:50 UTC)
| Price | USD 0.25 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.25 |
| Open | USD 0.25 |
| Day Range | USD 0.25 – 0.26 |
| 52-Week Range | USD 0.16 – 0.86 |
| Volume | 425,243 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (TOVX)
Nexqual's technical model rates TOVX "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 12:50 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 62.14 (neutral) |
| vs SMA50 | Above (USD 0.24) |
| MACD | 0 (positive) |
From TOVX's Latest SEC 10-K Filing (filed 2026-03-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AZTR | Azitra Inc | USD 0.18 | ▼ 1.1% |
| CMND | Clearmind Medicine Inc. | USD 1.16 | ▼ 37.3% |
| MGRX | Mangoceuticals, Inc. | USD 0.41 | ▲ 7.03% |
| BENF | Beneficient | USD 2.33 | ▲ 14.78% |
| VRAX | Virax Biolabs Group Limited | USD 2.63 | ▲ 3.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:50 UTC. This page is informational and not investment advice.